Presentation Information

Submitted Course

 

[SC-WE-54] Medical and Surgical Therapy of Cystoid Macular Edema in Uveitis
Go back
Day
Apr 02 (Wed)
Time
08:30 - 10:00
Room
Room 26 - Imperial Hotel 3F Ohgi
Topic
Uveitis, Intraocular Inflammation
 
 
print

SC-WE-54

Medical and Surgical Therapy of Cystoid Macular Edema in Uveitis

【Speaker】
Henry Kaplan Shlomit Schaal


Objective
At the conclusion of this course, the attendee will be able to develop a stepwise approach to the management of chronic CME in uveitis, including both medical and surgical intervention.

Summary of Content/Synopsis of the course
The major cause of visual loss in uveitis, regardless of etiology, is cystoid macular edema (CME). In most patients, CME will resolve with control of inflammation through corticosteroid therapy administered topically, periocularly, intravitreally, and/or systemically. In patients who are intolerant or nonresponsive to corticosteroids, the use of corticosteroid-sparing agents (e.g., cytotoxic or biologic drugs) may be useful. However, a subset of patients will have decreased vision secondary to CME regardless of the medical regimen employed. The role of an adherent posterior hyaloid over the macula in the persistence of CME in these cases has only recently been appreciated. In this course, the importance of OCT imaging in the diagnosis of vitreomacular traction and the therapeutic benefit of surgical removal of the posterior hyaloid in persistent CME associated with uveitis will be presented.

Target Audience
Subspecialists in uveitis and intraocular inflammation

Educational Level
Intermediate and advanced

[ Keyword ]
CME, posterior hyaloid, vitrectomy, corticosteroids, IMT

[ Conflict of Interest ]
No

Go back